Search for content, post, videos

Category

Agreement

björn-sjöstrand-agreement
0 COMMENT
56 Views
Scandinavian Biopharma in agreement with Flynn Pharma

Scandinavian Biopharma has entered into an agreement with Flynn Pharma for the viper antivenom ViperaTAb. Under the agreement, Scandinavian Biopharma will have exclusive rights to service and make ViperaTAb available for emergency use in the Nordics, Baltic States and Germany. “We are very pleased to strengthen our portfolio with an…

bonesupport
0 COMMENT
79 Views
Bonesupport extends US distribution agreement

BONESUPPORT has extended the term of its U.S. distribution agreement with Zimmer Biomet, where Zimmer will continue to have exclusive rights for BONESUPPORT’s cerament bone void filler product line for Orthopedics, Trauma and Foot and Ankle indications in the United States. “We are extremely pleased to extend our distribution agreement…

jallal
0 COMMENT
69 Views
MedImmune forms development alliance with Sanofi Pasteur

Medimmune and Sanofi Pasteur have announced an agreement to develop and commercialise MEDI8897, a monoclonal antibody (mAb) for the prevention of lower respiratory tract illness (LRTI) caused by respiratory syncytial virus (RSV,) jointly. MEDI8897 is currently in a Phase IIb clinical trial in pre-term infants who are ineligible for Synagis, the…

signing-agreement
0 COMMENT
65 Views
Vironova signs agreement with the FDA

Vironova signs one-year agreement with the U.S. Food and Drug Administration to beta test proprietary Vironova Analyzing Software (VAS). In one of the fastest growing drug development areas today, nano-particles (for example liposomes), visible using electron microscopy, are used to deliver drugs to their exact targets in the body. Vironova…

mark_mallon
0 COMMENT
69 Views
AstraZeneca in agreement with TerSera Therapeutics

AstraZeneca has entered into an agreement with TerSera Therapeutics (TerSera) for the commercial rights to Zoladex (goserelin acetate implant) in the US and Canada. Zoladex is an injectable luteinising hormone-releasing hormone agonist, used to treat prostate cancer, breast cancer and certain benign gynaecological disorders. It was first approved in the…

sobi-lab
0 COMMENT
53 Views
Sobi enters distribution agreement

Swedish Orphan Biovitrum (Sobi) announces that the company has entered into a 3-year agreement with Valeant Pharmaceuticals Ireland for the distribution of Ammonul (sodium phenyl acetate and sodium benzoate) injection in Europe, the Middle East and North Africa. The new agreement replaces the current distribution agreement with Valeant Pharmaceuticals North…

truls-sjöstedt-brighter
0 COMMENT
59 Views
Brighter signs agreement with Sonat

Brighter has selected Sonat as its development partner for the upcoming launch of Actiste, Brighter’s connected diabetes solution. Sonat specializes in developing, managing and running logistics processes, and will together with Brighter develop a strong logistics platform that facilitates growth and international expansion. Under the agreement, Sonat will take on…

Lena Söderström Senzime
0 COMMENT
39 Views
Senzime signs distribution agreement

Senzime has entered distribution agreements for the commercialization of TetraGraph with Wardray Premise, who will be the exclusive distributor in the UK and Ireland and LSR Healthcare who will be the exclusive distributor in Australia and New Zealand. Compensation to distributors will be paid on a “per-unit sold” basis, and…

agreement
0 COMMENT
33 Views
Enzymatica enters partnership agreement

Enzymatica enters into partnership agreement with STADA Arzneimittel which grants STADA exclusive rights to sell, market and distribute Enzymatica’s common cold product ColdZyme in Germany. Stada is a global pharmaceutical company, headquartered in Germany, with a strong presence in Europe and leading positions in the cough and cold category in…

tero-bc-platforms
0 COMMENT
39 Views
BC Platforms enters new partnership

BC Platforms has signed a partnership with Dartmouth-Hitchcock Medical Center’s laboratory of Clinical Genomics and Advanced Technology in the Department of Pathology & Laboratory Medicine in the US, focused on providing data management solutions in cancer research. BC Platforms will link clinical and genomic data from Dartmouth-Hitchcock’s tumour biobank to…

bactiguard
0 COMMENT
55 Views
Bactiguard and Smartwise in license agreement

Bactiguard and Smartwise Sweden have entered into a joint development project for advanced, Bactiguard-coated vascular injection catheters and at the same time, a license agreement has been signed. Under the agreement, Smartwise will pay USD 2.5 million, for the exclusive and global right to the Bactiguard technology for this application, payable…

ossdsign
0 COMMENT
38 Views
OssDsign announces new agreement

​OssDsign has signed an agreement with Matador Medical Inc. to act as its master distributor in the US market. OssDsign recently announced FDA 510(k) clearance of OSSDSIGN Cranial PSI, a patient-specific medical implant intended for reconstruction of cranial defects. Matador Medical was founded and is led by Paul Byerley, who…

peter_z_index_pharma
0 COMMENT
44 Views
InDex Pharmaceuticals enters agreement

InDex Pharmaceuticals Holding has entered an agreement for services with the global contract research organization (CRO) PAREXEL for the implementation of the CONDUCT study. The CONDUCT is a phase IIb dose optimisation study with the drug candidate cobitolimod for the treatment of moderate to severe active ulcerative colitis. According to…

novo-nordisk-oxford-center
0 COMMENT
51 Views
Novo Nordisk invests in new research center

University of Oxford and Novo Nordisk announces a landmark research collaboration focused on type 2 diabetes. The partnership will enable scientists from Novo Nordisk and University of Oxford to collaborate to discover innovative approaches for treating type 2 diabetes. As part of the collaboration, Novo Nordisk is also investing in…

0 COMMENT
41 Views
DermoScan and SciBase sign agreement

SciBase has signed an agreement with the German medical device company DermoScan to link Nevisense with its EIS measurement for early detection of malignant melanoma, with DermoScan’s digital dermoscopy system DermoGenius Ultra. DermoScan is one of Europe’s foremost manufacturers of digital dermoscopy systems. The agreement means that EIS measurements from…